Clinical Trial Update: Efficacy and Safety of iGlarLixi Versus Insulin Glargine Plus Dulaglutide in Patients With Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 trial comparing iGlarLixi to insulin glargine plus dulaglutide for efficacy and safety in type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dulaglutide (dulaglutide)
• Insulin Glargine (insulin glargine)
• iGlarLixi (insulin glargine + lixisenatide)

Snippet

Sponsor: Chungbuk National University Hospital | Conditions: Type 2 Diabetes Mellitus, Glucose, High Blood | Phase 4 | Status: UNKNOWN